The Effect of Drug Use, Body Mass Index and Blood Pressure on Oxidative Stress Levels in Children and Adolescents with Attention Deficit and Hyperactivity Disorder

被引:1
|
作者
Miniksar, Dilsadi Yildiz [1 ,4 ]
Cans, Mehmet Akif [1 ]
Miniksar, Hakan [2 ]
Kitc, Mahmut [3 ]
Minisker, Okkes Hakan [3 ]
机构
[1] Yozgat Bozok Univ, Dept Child & Adolescent Psychiat, Yozgat, Turkiye
[2] Yozgat Bozok Univ, Dept Publ Hlth, Yozgat, Turkiye
[3] Yozgat Bozok Univ, Dept Anesthesiol & Reanimat, Yozgat, Turkiye
[4] Yozgat Bozok Univ, Dept Child & Adolescent Psychiat, Ataturk Rd 7, TR-66100 Yozgat, Turkiye
关键词
  Attention deficit hyperactivity disorder; Oxidative stress; Malondialdehyde; Superoxide dismutase; FREE-RADICAL PATHOLOGY; DEFICIT/HYPERACTIVITY DISORDER; DNA-DAMAGE; SCHIZOPHRENIA; SUPPLEMENTATION; METABOLISM; IMBALANCE; DOPAMINE; MARKERS; OBESITY;
D O I
10.9758/cpn.2023.21.1.88
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objective: The aim of this study was to determine the correlation between clinical variables such as body mass index, blood pressure, drug use and oxidative stress level in children and adolescents with attention deficit and hyperactivity disorder (ADHD). Methods: Total oxidant status (TOS), total antioxidant status (TAS), oxidative stress index (OSI), malondialdehyde (MDA) and superoxide dismutase (SOD) activity were measured in the serum of 51 patients (38 male, 13 female) diagnosed with ADHD according to DSM-5 diagnostic criteria and 32 control subjects (12 male, 20 female). The Kiddie Schedule for Affective Disorders and Schizophrenia Present and Lifetime Version was applied to all participants. Results: The mean TOS, OSI, MDA values were determined to be significantly higher (p < 0.001) and the mean SOD value was lower in the ADHD group (p < 0.001). Multivariate regression analysis indicated significantly lower SOD and diastolic blood pressure values and significantly higher MDA in the ADHD group compared to the control group (p < 0.01). Low SOD (sensitivity 90.2%, specificity 78.0%) and high MDA (sensitivity 86.3%, specificity 81.2%) were determined to be predictive parameters for diagnosing ADHD. In univariate analysis, the mean TOS, OSI and SOD values were higher in ADHD patients under medication, while the mean TAS was higher in patients not using medi-cation (p < 0.01). Only TOS was significant in multivariate logistic regression analysis (p < 0.01). Conclusion: The results of this study demonstrate that impaired oxidative balance may play a role in the etiology of ADHD.
引用
收藏
页码:88 / 98
页数:11
相关论文
共 50 条
  • [21] Serum Copper and Ceruloplasmin Levels in Children and Adolescents with Attention Deficit Hyperactivity Disorder
    Kul, Muslum
    Kara, Mahmut
    Unal, Fatih
    Tuzun, Zeynep
    Akbiyik, Filiz
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 24 (02): : 139 - 145
  • [22] Increased Serum Hepcidin Levels in Children and Adolescents with Attention Deficit Hyperactivity Disorder
    Yazici, Kemal Utku
    Yazici, Ipek Percinel
    Ustundag, Bilal
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2019, 17 (01) : 105 - 112
  • [23] Attention deficit hyperactivity disorder (ADHD) in children and adolescents
    Said, Zead
    Huzair, Hifzi
    Helal, Muhammad Nabeel
    Mushtaq, Imran
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2015, 19 (03) : 16 - 23
  • [24] Attention Deficit-Hyperactivity Disorder in Children and Adolescents
    Feldman, Heidi M.
    Reiff, Michael I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (09): : 838 - 846
  • [25] Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
    Carbray, Julie A.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2018, 56 (12) : 7 - 10
  • [26] Amphetamines for attention deficit hyperactivity disorder in children and adolescents
    Feldman, Mark E.
    PAEDIATRICS & CHILD HEALTH, 2017, 22 (05) : 288 - +
  • [27] Attention-deficit/hyperactivity disorder in children and adolescents
    Dunn, DW
    Kronenberger, WG
    NEUROLOGIC CLINICS, 2003, 21 (04) : 933 - +
  • [28] Attention deficit hyperactivity disorder and enuresis in children and adolescents
    Zavadenko N.N.
    Kolobova N.M.
    Suvorinova N.Yu.
    Neuroscience and Behavioral Physiology, 2011, 41 (5) : 525 - 531
  • [29] Venlafaxine in children and adolescents with attention deficit hyperactivity disorder
    Mukaddes, NM
    Abali, O
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2004, 58 (01) : 92 - 95
  • [30] Association of Stimulant Medication Use With Bone Mass in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
    Feuer, Alexis J.
    Thai, Ashley
    Demmer, Ryan T.
    Vogiatzi, Maria
    JAMA PEDIATRICS, 2016, 170 (12)